Dubowitz syndrome is a disorder involving craniofacial abnormalities, growth retardation and mental retardation. Approximately 142 cases have been reported, with various associated other anomalies. These include cardiovascular, urogenital and endocrine abnormalities, as well as a predisposition to infections and hematological malignancies. Scoliosis has been described in association with this syndrome, as have isolated vertebral abnormalities. There has, however, been no description of craniocervical abnormalities. We describe three Dubowitz patients with significant craniocervical abnormalities.

Keywords:
Dubowitz syndrome, Craniocervical abnormalities, Cervical spine abnormalities
1.
Dubowitz V: Familial low birth weight dwarfism with an unusual facies and a skin eruption. J Med Genet 1965;2:12–17.
2.
Vogels A, Lorenzetti ME, Gillio P, Fryns JP: Facial asymmetry, cardiovascular anomalies, and adducted thumbs as unusual symptoms in Dubowitz syndrome? Ann Genet 1996;39:31–34.
3.
Gomirato G, Bona F, Basano R: Dubowitz syndrome with special characteristics. Panminerva Med 1992;34:141–144.
4.
Tsukahara M, Opitz JM: Dubowitz syndrome: Review of 141 cases including 36 previously unreported patients. Am J Med Genet 1996;63:277–289.
5.
Wilroy RS Jr, Tipton RE, Summitt RL: The Dubowitz syndrome. Am J Genet 1978;2:275–284.
6.
Hirano T, Izumi I, Tamura K: Growth hormone deficiency in Dubowitz syndrome. Acta Paediatr Jpn 1996;38:267–269.
7.
Lerman-Sagie T, Merlob P, Shuper A, Kauli R, Kozokaro Z, Grunebaum M, Mimouni M: New findings in a patient with Dubowitz syndrome: Velopharyngeal insufficiency and hypoparathyroidism. Am J Med Genet 1990;37:241–243.
8.
Ahmad A, Amalfitano A, Chen YT, Kishnani PS, Miller C, Kelley R: Dubowitz syndrome. A defect in the cholesterol biosynthetic pathway? (letter). Am J Med Genet 1999;86:503–504.
9.
Al-Nemri AR, Kilani RA, Salih MAM, Al-Ajlan AA: Embryonal rhabdomyosarcoma and chromosomal breakage in a newborn infant with possible Dubowitz syndrome. Am J Med Genet 2000;92:107–110.
10.
Antoniades K, Hatzistilianou M, Pitsavas G, Agouridaki C, Athanassiadou F: Co-existence of Dubowitz and hyper-IgE syndromes: A case report. Eur J Pediatr 1996;155:390–392.
11.
Belohradsky BH, Egger J, Meiswinkel M, Knoop M, Weiss M, Sauer O: Das Dubowitz-Syndrom. Ergeb Inn Med Kinderheilkd 1988;57:145–184.
12.
Gröbe H: Dubowitz-Syndrom und akute lymphatische Leukämie. Monatsschr Kinderheilkd 1983;131:467–468.
13.
Hansen KE, Kirkpatrick SJ, Laxova R: Dubowitz syndrome: Long-term follow-up of an original patient. Am J Med Genet 1995;55:161–164.
14.
Hochreutener H, Schinzel A, Baerlocher K: Das Dubowitz-Syndrom: Ein Dysmorphiesyndrom mit Entwicklungsrückstand, transitorischem Kleinwuchs, hyperaktivem Verhalten und atopischer Dermatitis. Monatsschr Kinderheilkd 1990;138:689–691.
15.
Paradisi M, Angelo C, Conti G, Mostaccioli S, Cianchini G, Atzori F, Puddu P: Dubowitz syndrome with keloidal lesions. Clin Exp Dermatol 1994;19:425–427.
16.
Sauer O, Spelger G: Dubowitz-Syndrom mit Immundefizienz und malignem Neoplasma bei zwei Geschwistern. Monatsschr Kinderheilkd 1977;125:885–887.
17.
Vieluf D, Korting HC, Braun-Falco O, Walther JU: Dubowitz syndrome: Atopic dermatitis, low birth weight dwarfism and facial dysmorphism. Dermatologica 1990;180:247–249.
18.
Fryns JP, Fabry G, Willemyns F, Van den Berghe H: Brief clinical report: The Dubowitz syndrome in a teenager. Am J Med Genet 1979;4:345–347.
19.
Soyer AD, McConnell JR: Progressive scoliosis in Dubowitz syndrome. Spine 1995;20:2335–2337.
20.
Grosse R, Gorlin J, Opitz JM: The Dubowitz syndrome. Z Kinderheilkd 1971;110:175–187.
21.
Berthold F, Fuhrmann W, Lampert F: Fatal aplastic anaemia in a child with features of Dubowitz syndrome. Eur J Pediatr 1987;146:605–607.
22.
Moller KT, Gorlin RJ: The Dubowitz syndrome: A retrospective. J Craniofac Genet Dev Biol Suppl 1985;1:283–286.
23.
Thuret I, Michel G, Philip N, Hairion D, Capodano AM, Perrimond H: Chromosomal instability in two siblings with Dubowitz syndrome. Br J Haematol 1991;78:124–125.
24.
Dumic M, Cvitkovic M, Letinic D, Filipovic-Grcic B, Kordic R: Sindrom Dubowitz. Lijec Vjesn 1994;116:135–137.
25.
Ilyina HG, Lurie IW: Dubowitz syndrome: Possible evidence for a clinical subtype. Am J Med Genet 1990;35:561–565.
26.
Matheiu M, Berquin P, Epelbaum S, Lenaerts C, Piussan C: Le syndrome de Dubowitz. Un diagnostic à ne pas méconnaître. Arch Fr Pediatr 1991;48:715–718.
27.
Opitz JM, Pfeiffer RA, Hermann JPR, Kushnick T: Studies of malformation syndromes of man XXIV B: The Dubowitz syndrome. Further observations. Z Kinderheilkd 1973;116:1–12.
28.
Winter RM: Dubowitz syndrome. J Med Genet 1986;23:11–13.
29.
Wallerstein R, Kacmar J, Anderson CE, Jackson L: Dubowitz syndrome in a boy without developmental delay: Further evidence for phenotypic variability. Am J Med Genet 1997;68:216–218.
30.
Chrzanowska HW, Krajewska-Walasek M: The Dubowitz syndrome – one more case. Klin Pädiatr 1987;199:370–372.
31.
Kondo I, Takeda K, Kuwajima K, Hirano T: A Japanese patient with the Dubowitz syndrome. Clin Genet 1987;31:389–392.
32.
Küster W, Majewski F: The Dubowitz syndrome. Eur J Pediatr 1986;144:574–578.
33.
Majewski F, Michaelis R, Moosmann K, Bierich JR: A rare type of low birthweight dwarfism: The Dubowitz syndrome. Z Kinderheilkd 1975;120:283–292.
34.
Onuma A, Kobayashi Y, Iinuma K: The relationship between MR images and clinical findings in neuronal migrational disorders (in Japanese). No To Hattatsu 1997;29:285–290.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.